Home/Pipeline/ACT Genomics (OncoFusion)

ACT Genomics (OncoFusion)

Comprehensive Genomic Profiling for Solid Tumors

Approved/CommercialActive

Key Facts

Indication
Comprehensive Genomic Profiling for Solid Tumors
Phase
Approved/Commercial
Status
Active
Company

About Prenetics

Prenetics is a genomics-driven health sciences company with a mission to make health testing more accessible, actionable, and personalized. The company has established itself as a key player in the consumer genomics and diagnostic testing markets, notably through its large-scale COVID-19 testing operations in the UK and Hong Kong. Its core consumer product, CircleDNA, provides actionable health, wellness, and ancestry insights from whole genome sequencing. Prenetics is strategically expanding its portfolio through acquisitions and partnerships to build a comprehensive digital health ecosystem.

View full company profile